CGON
Cg Oncology Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$64.29
+1.32 ▲ +2.10%
🌙 3월 13일 7:44 PM ET (한국 3/14 08:44)
$65.27
+0.98 ▲ +1.52%
| Index | RUT | P/E | - | EPS (ttm) | -2.08 | Insider Own | 36.92% | Shs Outstand | 0.08B | Perf Week | 3.89% |
| Market Cap | 5.43B | Forward P/E | - | EPS next Y | 18.42% | Insider Trans | 4.89% | Shs Float | 0.05B | Perf Month | 20.06% |
| Enterprise Value | 4.69B | PEG | - | EPS next Q | -0.57 | Inst Own | 80.2% | Short Float | 17.45% | Perf Quarter | 54.02% |
| Income | -0.16B | P/S | 1343.65 | EPS this Y | -12.91% | Inst Trans | 0.86% | Short Ratio | 7.78 | Perf Half Y | 93.88% |
| Sales | 0.00B | P/B | 6.89 | EPS next 5Y | - | ROA | -20.82% | Short Interest | 9.29M | Perf YTD | 54.84% |
| Book/sh | 9.33 | P/C | 7.31 | EPS past 3/5Y | -46.89% -65.75% | ROE | -21.67% | 52W High | -0.59% ($64.67) | Perf Year | 147.75% |
| Cash/sh | 8.79 | P/FCF | - | Sales past 3/5Y | 176.56% -20.97% | ROIC | -21.22% | 52W Low | 334.39% ($14.80) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -80.13% | Gross Margin | -30.99% | Volatility(W/M) | 5.49% 5.63% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 1161.69 | Sales Y/Y TTM | 254.7% | Oper. Margin | -4722.13% | ATR (14) | 3.19 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 24.58 | EPS Q/Q | -23.52% | Profit Margin | -3985.02% | RSI (14) | 66.66 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 24.63 | Sales Q/Q | 409.21% | SMA20 | 8.84% ($59.07) | Beta | 1.02 | Target Price | $80.43 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2000000 | SMA50 | 18.61% ($54.2) | Rel Volume | 1.57 | Prev Close | $62.97 |
| Employees | 142 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | 8.39% 405.84% | SMA200 | 65.26% ($38.9) | Avg Volume(3M) | 1.19M | Price | $64.29 |
| IPO | 2024/1/25 | Option/Short | Yes/Yes | Trades | 14717 | Volume | 1,880,059 | Change | 2.1% |
뉴스 로딩 중...